General
LATITUDE and STAMPEDE: Abiraterone acetate + ADT a potential new standard-of-care for prostate cancer | News for Doctor, Nurse, Pharmacist | Multidisciplinary | MIMS Malaysia
 

LATITUDE and STAMPEDE: Abiraterone acetate + ADT a potential new standard-of-care for prostate cancer | News for Doctor, Nurse, Pharmacist | Multidisciplinary | MIMS Malaysia

Shared by:

 
LATITUDE and STAMPEDE: Abiraterone acetate + ADT a potential new standard-of-care for prostate cancer in American Society of Clinical Oncology (ASCO) 2017 Annual Meeting | MIMS Malaysia
 
specialty.mims.com
 
19 Jun 2017 - General